JAN 07, 2020 7:30 PM PST

Saliva Test for Early Detection of Mouth and Throat Cancer

WRITTEN BY: Nupur Srivastava

“Oropharyngeal cancers (OPC) is one of the fastest rising cancers in Western countries due to increasing Human Papilloma Virus (HPV)-related incidence, especially in younger patients. It is pre-eminent to develop surveillance methods that can help improve early detection and outcomes,” quoted co-lead investigator Tony Jun Huang from Duke University in the U.S.

Early detection of mouth and throat cancers is difficult because their location (in the back) makes it challenging to see by the health care providers during routine clinical exams.

Researchers from Duke University, UCLA, and the University of Birmingham in the U.K. report the development of a new noninvasive acoustofluidics test that analyzes saliva for the presence of HPV-16, the pathogenic strain associated with OPCs. The novel technique detected OPC in whole saliva in 40% of patients tested, and 80% of confirmed OPC patients. Results were published online December 13 in the Journal of Molecular Diagnostics.

The tiny 'acoustofluidic' chip separates exosomes in the saliva by removing unnecessary particles using a size-gradient isolation method. Exosomes are small microvesicles originating within cells that get secreted into body fluids. They play an essential role in intercellular communication, and their numbers elevate in association with several types of cancers. 

Acoustofluidic exosome isolation chip for salivary exosome isolation. The microfluidic channel is shown by a red dye solution and the coin demonstrates the size of the chip. Two pairs of gold interdigital transducers are deposited along the channel, which separates particles according to size. Image Credit: The Journal of Molecular Diagnostics

Why is the Acoustofluidics test advantageous?

  • The testing is efficient; even the saliva of a patient gets more or less viscous.
  • It is an automated and rapid process that can yield isolates exosomes as early as 5 minutes compared to the conventional methods, which might take more than 8 hours.
  • The testing costs less than other similar technologies used currently.
  • It is very much non-invasive, allowing continuous long-term monitoring of patients to assess the progression of the tumor.
  • This testing method can be easily put into practice clinically.

"The saliva exosome liquid biopsy is an effective early detection and risk assessment approach for OPC," said co-lead investigator David T.W. Wong, DMD, DMSc, of the Center for Oral/Head and Neck Oncology Research, School of Dentistry at the University of California Los Angeles, CA, USA.

Source: Eurekalert, NewsMedicalNet, Journal of Molecular Diagnostics

About the Author
You May Also Like
DEC 26, 2020
Clinical & Molecular DX
Navigating the Genomic Landscape of Cancer in Asians
DEC 26, 2020
Navigating the Genomic Landscape of Cancer in Asians
Precision medicine — a clinical paradigm that tailors treatments specifically to patients based on their genetic a ...
JAN 13, 2021
Clinical & Molecular DX
E-Stethoscope Picks up Good (and Bad) Vibrations
JAN 13, 2021
E-Stethoscope Picks up Good (and Bad) Vibrations
A medical device used to survey lung sounds to monitor for signs of respiratory distress has received FDA clearance. RES ...
JAN 18, 2021
Cancer
An "E-Nose" Could Help Doctors Diagnose Breast Cancer and Its Subtypes
JAN 18, 2021
An "E-Nose" Could Help Doctors Diagnose Breast Cancer and Its Subtypes
Breast cancer is one of the most well-studied cancers in modern medicine. Diagnostics can already differentiate between ...
FEB 25, 2021
Clinical & Molecular DX
Pure Gold: Mini Device Makes 3D Skin Maps
FEB 25, 2021
Pure Gold: Mini Device Makes 3D Skin Maps
Beauty is skin deep and so are wounds. Closely monitoring wound healing progress has been a challenge for doctors, mainl ...
MAR 04, 2021
Clinical & Molecular DX
Is the Cancer Treatment Working? Liquid Biopsies Provide Answers.
MAR 04, 2021
Is the Cancer Treatment Working? Liquid Biopsies Provide Answers.
A newly-developed tool could help physicians monitor the performance of colorectal cancer therapies simply by examining ...
APR 27, 2021
Clinical & Molecular DX
No Batteries: Health Sensor Harvests Biomechanical Energy
APR 27, 2021
No Batteries: Health Sensor Harvests Biomechanical Energy
An international team of researchers has developed a wearable health monitor that works without the need for batteries. ...
Loading Comments...